Sign in

CIK 0001088856 · Large accelerated filer

CORCEPT THERAPEUTICS INC

Sign in to watch
Ticker
CORT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770487658
Phone
650.688.8803
Business address
101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$41,067,988
in 15 filings, $36.6M under 10b5-1 plans

Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. MAHONEY DAVID L −$12.3M Director sold 8% of stake
  2. Maduck Sean −$11.7M See Remarks sold 91% of stake
  3. Vieira Roberto Wandenkolk −$8.1M President, Oncology sold 95% of stake
  4. Park Kimberly −$3.3M Director sold 100% of stake
  5. Lyon Joseph Douglas −$2.3M See Remarks sold 78% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-05 Robb Gary Charles Chief Business Officer Option exercise · Stock option (right to buy) −45,000 0
2023-05-05 Robb Gary Charles Chief Business Officer Option exercise · Stock option (right to buy) −60,000 38,963
2023-03-01 Maduck Sean See Remarks Gift −1,460 38,646
2023-03-01 Maduck Sean See Remarks Other acquisition +1,460 56,976
2023-03-01 Maduck Sean See Remarks Grant or award +1,460 $19.86 $29K 57,922
2023-03-01 Maduck Sean See Remarks Grant or award +1,460 59,382
2023-03-01 Mokari Atabak Chief Financial Officer Grant or award +1,260 $19.86 $25K 2,846
2023-03-01 Mokari Atabak Chief Financial Officer Grant or award +1,260 4,106
2023-03-01 Robb Gary Charles Chief Business Officer Grant or award +1,600 $19.86 $32K 17,983
2023-03-01 Robb Gary Charles Chief Business Officer Grant or award +1,600 19,583
2023-03-01 Guyer William Chief Development Officer Grant or award +1,472 $19.86 $29K 3,316
2023-03-01 Guyer William Chief Development Officer Grant or award +1,472 4,788
2023-03-01 Lyon Joseph Douglas Chief Accounting Officer Grant or award +1,155 $19.86 $23K 1,155
2023-03-01 Lyon Joseph Douglas Chief Accounting Officer Grant or award +1,155 2,310
2023-02-13 Robb Gary Charles Chief Business Officer Grant or award · Stock option (right to buy) +200,000 200,000
2023-02-13 Guyer William Chief Development Officer Grant or award · Stock option (right to buy) +200,000 200,000
2023-02-13 Lyon Joseph Douglas Chief Accounting Officer Grant or award · Stock option (right to buy) +120,000 120,000
2023-02-13 Hunt Hazel Chief Scientific Officer Grant or award · Stock option (right to buy) +200,000 200,000
2023-02-13 Mokari Atabak Chief Financial Officer Grant or award · Stock option (right to buy) +200,000 200,000
2023-02-13 BELANOFF JOSEPH K Chief Executive Officer Grant or award · Stock option (right to buy) +500,000 500,000

Page 52 of 61 · 1,220 trades